BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deyama S, Minami M, Kaneda K. Resolvins as potential candidates for the treatment of major depressive disorder. J Pharmacol Sci 2021;147:33-9. [PMID: 34294370 DOI: 10.1016/j.jphs.2021.05.002] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
Number Citing Articles
1 Deyama S, Kaneda K. Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine. Neuropharmacology 2023;224:109335. [PMID: 36403852 DOI: 10.1016/j.neuropharm.2022.109335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Deyama S, Aoki S, Sugie R, Fukuda H, Shuto S, Minami M, Kaneda K. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex. Neurotherapeutics 2023. [PMID: 36622634 DOI: 10.1007/s13311-022-01337-1] [Reference Citation Analysis]
3 Polityńska B, Pokorska O, Wojtukiewicz AM, Sawicka M, Myśliwiec M, Honn KV, Tucker SC, Wojtukiewicz MZ. Is depression the missing link between inflammatory mediators and cancer? Pharmacol Ther 2022;240:108293. [PMID: 36216210 DOI: 10.1016/j.pharmthera.2022.108293] [Reference Citation Analysis]
4 Liu C, Fan D, Lei Q, Lu A, He X. Roles of Resolvins in Chronic Inflammatory Response. Int J Mol Sci 2022;23. [PMID: 36499209 DOI: 10.3390/ijms232314883] [Reference Citation Analysis]
5 Deyama S, Kaneda K, Minami M. Resolution of depression: Antidepressant actions of resolvins. Neuroscience Research 2022. [DOI: 10.1016/j.neures.2022.10.006] [Reference Citation Analysis]
6 Leão FF, Waltrick APF, Verri WA, da Cunha JM, Zanoveli JM. Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model. Naunyn-Schmiedeberg's Arch Pharmacol. [DOI: 10.1007/s00210-022-02274-8] [Reference Citation Analysis]
7 Kalinkovich A, Becker M, Livshits G. New Horizons in the Treatment of Age-Associated Obesity, Sarcopenia and Osteoporosis. Drugs Aging 2022. [PMID: 35781216 DOI: 10.1007/s40266-022-00960-z] [Reference Citation Analysis]
8 Kotlyarov S, Kotlyarova A. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis. Int J Mol Sci 2022;23:4808. [PMID: 35563200 DOI: 10.3390/ijms23094808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Aoki S, Deyama S, Sugie R, Ishimura K, Fukuda H, Shuto S, Minami M, Kaneda K. The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice. Behav Brain Res 2022;418:113676. [PMID: 34801580 DOI: 10.1016/j.bbr.2021.113676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]